In an address during the American Urological Association’s 2020 Live Virtual Experience, Anthony S. Fauci, MD, a member of the White House Coronavirus Task Force, said the coronavirus pandemic is nowhere near over, but public health measures are making a big difference in reducing the number of cases and related deaths.
Previous retrospective studies have suggested that 5-alpha-reductase inhibitors may beneficial effects on bladder cancer development and/or recurrence, but a prospective cohort study found no protective effect.
A study of patients undergoing radical prostatectomy found that those chronic kidney disease or end-stage renal disease have a higher risk of 30- and 90-day readmission and 1-year mortality.
In a retrospective study, addition of carboplatin to chemotherapy regimens improved survival in men with metastatic castration-resistant prostate cancer whose disease progressed on second-generation hormone therapy.
Findings from a new study can help individualize prognoses for men with biochemical recurrence of prostate cancer after radical prostatectomy.
Decreased frequency of surveillance cystoscopies did not increase the risk of bladder cancer progression or death, study finds.
In a study of T2 to T3 RCC patients, lymph node dissection did not significantly improve overall survival.
Combination radiation treatment and radical prostatectectomy Gleason 9 to 10 prostate cancer are associated with similar cancer-specific mortality, a study found.
Testosterone levels among adolescents and young men in the United States declined significantly from 1999 to 2016, and data suggest the trend is related to increases in body mass index, a study found.
Cytoreductive radical prostatectomy following neoadjuvant androgen-deprivation therapy (ADT) in men with hormone-naïve low-volume metastatic prostate cancer improves survival long-term vs ADT alone, a study found.
Please login or register first to view this content.
